Surgery Partners Aktie
12,60
EUR
-0,10
EUR
-0,79
%
14,55
USD
+0,34
USD
+2,39
%
Surgery Partners jetzt ohne Ordergebühren (zzgl. Spreads) handeln beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Surgery Partners Aktie Analyse
| 28.06.18 | Surgery Partners Hold | Stifel, Nicolaus & Co., Inc. | |
| 30.01.18 | Surgery Partners Buy | The Benchmark Company | |
| 09.08.17 | Surgery Partners Sell | Stifel, Nicolaus & Co., Inc. | |
| 24.04.17 | Surgery Partners Hold | Stifel, Nicolaus & Co., Inc. | |
| 10.03.17 | Surgery Partners Hold | Stifel, Nicolaus & Co., Inc. | |
| 31.01.17 | Surgery Partners Buy | The Benchmark Company | |
| 14.03.16 | Surgery Partners Outperform | RBC Capital Markets | |
| 27.10.15 | Surgery Partners Buy | Stifel, Nicolaus & Co., Inc. | |
|
Werbung
|
|||
| 26.10.15 | Surgery Partners Outperform | RBC Capital Markets | |
Werbung
Werbung